Search Results - "GARIBOTTO, V"

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework by Leuzy, A., Ashton, N. J., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R., Zetterberg, H., Blennow, K., Frisoni, G. B., Garibotto, V., Hansson, O.

“…Purpose In the last decade, the research community has focused on defining reliable biomarkers for the early detection of Alzheimer’s disease (AD) pathology…”
Get full text

The logopenic/phonological variant of primary progressive aphasia by GORNO-TEMPINI, M. L, BRAMBATI, S. M, GINEX, V, OGAR, J, DRONKERS, N. F, MARCONE, A, PERANI, D, GARIBOTTO, V, CAPPA, S. F, MILLER, B. L

“…Primary progressive aphasia (PPA) is characterized by isolated decline in language functions. Semantic dementia and progressive nonfluent aphasia are accepted…”
Get full text

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers by Ashton, N. J., Leuzy, A., Karikari, T. K., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R., Zetterberg, H., Blennow, K., Frisoni, G. B., Garibotto, V., Hansson, O.

“…Purpose The development of blood biomarkers that reflect Alzheimer’s disease (AD) pathophysiology (phosphorylated tau and amyloid-β) has offered potential as…”
Get full text

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework by Wolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Hansson, O., Nordberg, A., Frisoni, G. B., Garibotto, V., Ossenkoppele, R.

“…Purpose In 2017, the Geneva Alzheimer’s disease (AD) Biomarker Roadmap initiative adapted the framework of the systematic validation of oncological diagnostic…”
Get full text

Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study by Pievani, M., Ribaldi, F., Toussas, K., Da Costa, S., Jorge, J., Reynaud, O., Chicherio, C., Blouin, J.L., Scheffler, M., Garibotto, V., Jovicich, J., Jelescu, I.O., Frisoni, G.B.

“…Resting-state functional connectivity (FC) MRI is sensitive to brain changes in Alzheimer’s disease in preclinical stages, however studies in persons with…”
Get full text

In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease by Iannaccone, S, Cerami, C, Alessio, M, Garibotto, V, Panzacchi, A, Olivieri, S, Gelsomino, G, Moresco, R.M, Perani, D

“…Abstract Background Reactive microgliosis, hallmark of neuroinflammation, may contribute to neuronal degeneration, as shown in several neurodegenerative…”
Get full text

Individual Detection of Patients with Parkinson Disease using Support Vector Machine Analysis of Diffusion Tensor Imaging Data: Initial Results by HALLER, S, BADOUD, S, NGUYEN, D, GARIBOTTO, V, LOVBLAD, K. O, BURKHARD, P. R

“…Brain MR imaging is routinely performed in the work-up of suspected PD, yet its role is essentially limited to the exclusion of other pathologies. We performed…”
Get full text

Disorganization of anatomical connectivity in obsessive compulsive disorder: A multi-parameter diffusion tensor imaging study in a subpopulation of patients by Garibotto, V, Scifo, P, Gorini, A, Alonso, Clarke R, Brambati, S, Bellodi, L, Perani, D

“…Abstract Obsessive–compulsive disorder (OCD) is thought to involve large-scale brain systems but the anatomical connectivity via association fibers has not…”
Get full text

Education and occupation as proxies for reserve in aMCI converters and AD FDG-PET evidence by GARIBOTTO, V, BORRONI, B, PERANI, D, KALBE, E, HERHOLZ, K, SALMON, E, HOLTOFF, V, SORBI, S, CAPPA, S. F, PADOVANI, A, FAZIO, F

“…Previous reports have shown that higher education is associated with more severe brain pathology in patients with Alzheimer disease (AD), suggesting that these…”
Get full text

Dementia prevention in memory clinics: recommendations from the European task force for brain health services by Frisoni, Giovanni B., Altomare, Daniele, Ribaldi, Federica, Villain, Nicolas, Brayne, Carol, Mukadam, Naaheed, Abramowicz, Marc, Barkhof, Frederik, Berthier, Marcelo, Bieler-Aeschlimann, Melanie, Blennow, Kaj, Brioschi Guevara, Andrea, Carrera, Emmanuel, Chételat, Gaël, Csajka, Chantal, Demonet, Jean-François, Dodich, Alessandra, Garibotto, Valentina, Georges, Jean, Hurst, Samia, Jessen, Frank, Kivipelto, Miia, Llewellyn, David J., McWhirter, Laura, Milne, Richard, Minguillón, Carolina, Miniussi, Carlo, Molinuevo, José Luis, Nilsson, Peter M., Noyce, Alastair, Ranson, Janice M., Grau-Rivera, Oriol, Schott, Jonathan M., Solomon, Alina, Stephen, Ruth, van der Flier, Wiesje, van Duijn, Cornelia, Vellas, Bruno, Visser, Leonie N.C., Cummings, Jeffrey L., Scheltens, Philip, Ritchie, Craig, Dubois, Bruno

“…Observational population studies indicate that prevention of dementia and cognitive decline is being accomplished, possibly as an unintended result of better…”
Get full text

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update by Boccardi, Marina, Dodich, Alessandra, Albanese, Emiliano, Gayet-Ageron, Angèle, Festari, Cristina, Ashton, Nicholas J., Bischof, Gérard N., Chiotis, Konstantinos, Leuzy, Antoine, Wolters, Emma E., Walter, Martin A., Rabinovici, Gil D., Carrillo, Maria, Drzezga, Alexander, Hansson, Oskar, Nordberg, Agneta, Ossenkoppele, Rik, Villemagne, Victor L., Winblad, Bengt, Frisoni, Giovanni B., Garibotto, Valentina

“…Background The 2017 Alzheimer’s disease (AD) Strategic Biomarker Roadmap (SBR) structured the validation of AD diagnostic biomarkers into 5 phases,…”
Get full text

A kinetics-based approach to amyloid PET semi-quantification by Chincarini, A., Peira, E., Corosu, M., Morbelli, S., Bauckneht, M., Capitanio, S., Pardini, M., Arnaldi, D., Vellani, C., D’Ambrosio, D., Garibotto, V., Assal, F., Paghera, B., Savelli, G., Stefanelli, A., Guerra, U. P., Nobili, F.

“…Purpose To develop and validate a semi-quantification method (time-delayed ratio, TDr) applied to amyloid PET scans, based on tracer kinetics information…”
Get full text

Education and occupation provide reserve in both ApoE epsilon 4 carrier and noncarrier patients with probable Alzheimer's disease by Garibotto, V, Borroni, B, Sorbi, S, Cappa, S F, Padovani, A, Perani, D

“…According to the reserve hypothesis, a high educational/occupational attainment can modulate Alzheimer's disease (AD) clinical expression. The impact of the…”
Get full text

Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer’s disease by Garibotto, V., Borroni, B., Sorbi, S., Cappa, S. F., Padovani, A., Perani, D.

“…According to the reserve hypothesis, a high educational/occupational attainment can modulate Alzheimer’s disease (AD) clinical expression. The impact of the…”
Get full text

Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? by Premi, E, Pilotto, A, Garibotto, V, Bigni, B, Turrone, R, Alberici, A, Cottini, E, Poli, L, Bianchi, M, Formenti, A, Cosseddu, M, Gazzina, S, Magoni, M, Bertoli, M, Paghera, B, Borroni, B, Padovani, A

“…Abstract Background Impulse Control Disorder symptoms (ICD) in Parkinson's disease (PD) has been recently associated by magnetic Resonance imaging with…”
Get full text

Semi-quantification and grading of amyloid PET: a project of the European Alzheimer's Disease Consortium (EADC) by Chincarini, A., Peira, E., Morbelli, S., Pardini, M., Bauckneht, M., Arbizu, J., Castelo-Branco, Miguel, Büsing, K. A., de Mendonça, Alexandre, Didic, M., Dottorini, M., Engelborghs, S., Ferrarese, C., Frisoni, G. B., Garibotto, V., Guedj, E., Hausner, L., Hugon, J., Verhaeghe, J., Mecocci, P., Musarra, M., Queneau, M., Riverol, M., Santana, I., Guerra, U. P., Nobili, F.

“…© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/)…”
Get full text

Severe early basal ganglia hypometabolism in neurodegeneration with brain iron accumulation by Mainta, Ismini C., Tabouret-Viaud, C., Horvath, J., Vargas, M. I., Garibotto, V.

Get full text

Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging by Premi, Enrico, Calhoun, V. D., Garibotto, V., Turrone, R., Alberici, A., Cottini, E., Pilotto, A., Gazzina, S., Magoni, M., Paghera, B., Borroni, B., Padovani, A.

“…Purpose [ 123 I]FP-CIT (DaTSCAN®) single-photon emission computed tomography (SPECT) imaging is widely used to study neurodegenerative parkinsonism, by…”
Get full text

Amyloid-PET and 18 F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias by Chételat, Gaël, Arbizu, Javier, Barthel, Henryk, Garibotto, Valentina, Law, Ian, Morbelli, Silvia, Elsmarieke van de Giessen, Agosta, Federica, Barkhof, Frederik, Brooks, David J, Carrillo, Maria C, Dubois, Bruno, Fjell, Anders M, Frisoni, Giovanni B, Hansson, Oskar, Herholz, Karl, Hutton, Brian F, Jack, Clifford R, Lammertsma, Adriaan A, Landau, Susan M, Minoshima, Satoshi, Nobili, Flavio, Nordberg, Agneta, Ossenkoppele, Rik, Oyen, Wim J G, Perani, Daniela, Rabinovici, Gil D, Scheltens, Philip, Villemagne, Victor L, Zetterberg, Henrik, Drzezga, Alexander

“…Summary Various biomarkers are available to support the diagnosis of neurodegenerative diseases in clinical and research settings. Among the molecular imaging…”
Get full text

Nature versus nurture in frontotemporal lobar degeneration: the interaction of genetic background and education on brain damage by Premi, E, Garibotto, V, Alberici, A, Paghera, B, Giubbini, R, Padovani, A, Borroni, B

“…Frontotemporal lobar degeneration (FTLD) is a progressive neurodegenerative disorder with a strong genetic background. It has been reported that modifiable…”
Get more information